Evaluation of Four Commercially Available Rapid Serologic Tests for Diagnosis of Leptospirosis

Journal of Clinical Microbiology - Tập 41 Số 2 - Trang 803-809 - 2003
Mary D. Bajani1, David A. Ashford1, Sandra L. Bragg1, Christopher W. Woods1, Tin Tin Aye1, Richard A. Spiegel1, Brian D. Plikaytis2, Bradley A. Perkins1, Maureen Phelan2, Paul N. Levett1, Robbin S. Weyant1
1Meningitis and Special Pathogens Branch
2Biostatistics and Information Management Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333

Tóm tắt

ABSTRACT Four rapid tests for the serologic diagnosis of leptospirosis were evaluated, and the performance of each was compared with that of the current standard, the microscopic agglutination test (MAT). The four rapid tests were a microplate immunoglobulin M (IgM)-enzyme-linked immunosorbent assay (ELISA), an indirect hemagglutination assay (IHA), an IgM dipstick assay (LDS), and an IgM dot-ELISA dipstick test (DST). A panel of 276 sera from 133 cases of leptospirosis from four different geographic locations was tested as well as 642 sera from normal individuals or individuals with other infectious or autoimmune diseases. Acute-phase sera from cases ( n = 148) were collected ≤14 days (median = 6.0) after the onset of symptoms, and convalescent-phase sera ( n = 128) were collected ≥15 days after onset (median = 29.1). By a traditional method (two-by-two contingency table), the sensitivities for detection of leptospirosis cases were 93.2% by LDS, 92.5% by DST, 86.5% by ELISA, and 79.0% by IHA. Specificity was 98.8% by DST, 97% by ELISA and MAT, 95.8% by IHA, and 89.6% by LDS. With a latent class analysis (LCA) model that included all the rapid tests and the clinical case definition, sensitivity was 95.5% by DST, 94.5% by LDS, 89.9% by ELISA, and 81.1% by IHA. The sensitivity and specificity estimated by the traditional methods were quite close to the LCA estimates. However, LCA allowed estimation of the sensitivity of the MAT (98.2%), which traditional methods do not allow. For acute-phase sera, sensitivity was 52.7% by LDS, 50.0% by DST, 48.7% by MAT and ELISA, and 38.5% by IHA. The sensitivity for convalescent-phase sera was 93.8% by MAT, 84.4% by DST, 83.6% by LDS, 75.0% by ELISA, and 67.2% by IHA. A good overall correlation with the MAT was obtained for each of the assays, with the highest concordance being with the DST (kappa value, 0.85; 95% confidence interval [CI], 0.8 to 0.90). The best correlation was between ELISA and DST (kappa value, 0.86; 95% CI, 0.81 to 0.91). False-positive LDS results were frequent (≥20%) in sera from individuals with Epstein-Barr virus, human immunodeficiency virus, and periodontal disease and from healthy volunteers. The ease of use and significantly high sensitivity and specificity of DST and ELISA make these good choices for diagnostic testing.

Từ khóa


Tài liệu tham khảo

10.1099/00222615-11-4-387

Adler, B., A. M. Murphy, S. A. Locarnini, and S. Faine. 1980. Detection of specific anti-leptospiral immunoglobulins M and G in human serum by solid-phase enzyme-linked immunosorbent assay. J. Med. Microbiol.11:452-457.

Arimitsu, Y., E. Kmety, Y. Ananyina, G. Baranton, I. R. Ferguson, L. Smythe, and W. J. Terpstra. 1994. Evaluation of the one-point microcapsule agglutination test for diagnosis of leptospirosis. Bull. W. H. O.72:395-399.

10.1017/S0950268899003040

10.1128/JCM.36.11.3138-3142.1998

10.2460/javma.2000.216.676

Carpenter A. B. 1997. Enzyme-linked immunoassays p. 20-29. In N. R. Rose E. C. de Macario J. D. Folds H. C. Lane and R. M. Nakamura (ed.) Manual of clinical laboratory immunology 5th ed. American Society for Microbiology Washington D.C.

Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance. Morb. Mortal. Wkly. Rep.46(RR-10):49.

Centers for Disease Control and Prevention. 1998. Outbreak of acute febrile illness among athletes participating in triathlons—Wisconsin and Illinois, 1998. Morbid. Mortal. Wkly. Rep.47:585-588.

10.1007/BF00145383

10.1128/am.25.6.976-980.1973

10.4269/ajtmh.1999.61.731

10.1023/A:1015509105668

Dawson-Saunders B. and R. Trapp. 1990. Basic and clinical biostatistics. Appleton and Lang New York N.Y.

10.1128/JCM.40.4.1464-1469.2002

10.1128/JCM.38.3.1081-1084.2000

Faine S. 1982. Guidelines for the control of leptospirosis. World Health Organization Geneva Switzerland.

Fleiss J. L. 1981. Statistical methods for rates and proportions 2nd ed. John Wiley & Sons New York N.Y.

10.1128/jcm.35.1.92-97.1997

10.1128/CMR.14.2.296-326.2001

10.1128/CDLI.8.2.349-351.2001

10.1128/JCM.36.1.11-14.1998

10.1086/340615

10.4269/ajtmh.1985.34.346

Perkins B. A. 1998. Epidemic leptospirosis associated with pulmonary hemorrhage in Nicaragua other recent outbreaks and diagnostic testing: issues and opportunities p. 159-167. In W. M. Scheld W. A. Craig and J. M. Hughes (ed.) Emerging infections 2. American Society for Microbiology Washington D.C.

10.1093/infdis/160.4.734

Ribeiro, M. A., C. C. Souza, and S. H. P. Almeida. 1995. Dot-ELISA for human leptospirosis employing immunodominant antigen. J. Trop. Med. Hyg.98:452-456.

10.4269/ajtmh.1999.61.399

Silva, M. V., E. D. Camargo, L. Batista, A. J. Vaz, A. P. Brandão, P. M. Nakamura, and J. M. Negrão. 1995. Behaviour of specific IgM, IgG and IgA class antibodies in human leptospirosis during the acute phase of the disease and during convalescence. J. Trop. Med. Hyg.98:268-272.

10.4269/ajtmh.1997.56.650

10.1128/JCM.37.9.2904-2909.1999

10.1046/j.1365-3156.2000.00525.x

10.1128/jcm.2.3.218-221.1975

Tappero J. W. D. A. Ashford and B. A. Perkins. 2000. Leptospira species (leptospirosis) p. 2495-2501. In G. L. Mandell J. E. Bennett and R. Dolin (ed.) Principles and practice of infectious diseases 5th ed. Churchill Livingstone Philadelphia Pa.

Terpstra, W. J., G. S. Ligthart, and G. J. Schoone. 1985. ELISA for the detection of specific IgM and IgG in human leptospirosis. J. Gen. Microbiol.131:377-385.

Terpstra, W. J., G. S. Ligthart, and G. J. Schoone. 1980. Serodiagnosis of human leptospirosis by enzyme-linked-immunosorbent-assay (ELISA). Zentbl. Bakteriol. Mikrobiol. Hyg. 1 Abt. Orig. A247:400-405.

10.1086/314424

Weyant R. S. S. L. Bragg and A. F. Kaufmann. 1999. Leptospira and Leptonema p. 739-745. In P. R. Murray E. J. Baron M. A. Pfaller F. C. Tenover and R. H. Yolken (ed.) Manual of clinical microbiology 7th ed. American Society for Microbiology Washington D.C.

10.1128/jcm.35.8.1938-1942.1997

World Health Organization. 1999. Leptospirosis worldwide, 1999. Wkly. Epidemiol. Rec.74:237-242.

10.1046/j.1365-3156.1999.00352.x

Thông tin
Thông tin xuất bản

Journal of Clinical Microbiology

Tập 41 Số 2

803-809

Thông tin tác giả